Literature DB >> 18754530

Evaluation of pupil mobility in patients with myasthenia gravis.

D Tsiptsios1, D F Fotiou, A B Haidich, G C Brozou, M Nakou, C Giantselidis, A Karlovasitou, F Fotiou.   

Abstract

The aim of this study is to investigate the effect of Myasthenia Gravis (MG) on the Central Nervous System (CNS) and/or the smooth muscles of the iris through pupillometry. Sixteen recently diagnosed Myasthenic and sixteen non-Myasthenic subjects of matching age and gender underwent a pupillometric study of the effects of single flash stimuli of 24.6 candelas/m2 intensity and 20 msec duration. A significant decrease in Amplitude (p < 0.001), Maximum Constriction Velocity (p < 0.001) and especially Maximum Constriction Acceleration with a perfect discrimination ability (AUC= 1, p < 0.001). was observed in the Myasthenic compared to the non-Myasthenic subjects. In contrast, no significant difference was observed in Baseline Pupil Radius (R1) and 3.5 secs Percentage Recovery-Redilatation (R%) (p = 0.051 and p = 0.517, respectively). Of the parameters that are studied, R1 and R% are governed mainly by the action of the Sympathetic Nervous System (SNS) and the rest by the Parasympathetic Nervous System (ParNS), through Acetylcholine. The analysis of these parameters demonstrates that the SNS remains unaltered while the ParNS may be affected in MG. This post-synaptic cholinergic receptors' deficit may be central, within the CNS, or peripheral, related to the Neuromuscular Junction of the iris' sphincter.

Entities:  

Mesh:

Year:  2008        PMID: 18754530

Source DB:  PubMed          Journal:  Electromyogr Clin Neurophysiol        ISSN: 0301-150X


  5 in total

1.  The use of pupillometry in the assessment of cardiac autonomic function in elite different type trained athletes.

Authors:  Antonia Kaltsatou; Evangelia Kouidi; Dimitrios Fotiou; Pantazis Deligiannis
Journal:  Eur J Appl Physiol       Date:  2011-01-23       Impact factor: 3.078

2.  The Spectrum of Autonomic Dysfunction in Myasthenic Crisis.

Authors:  Rohit Ninan Benjamin; Sanjith Aaron; Ajith Sivadasan; Suresh Devasahayam; Amalan Sebastin; Mathew Alexander
Journal:  Ann Indian Acad Neurol       Date:  2018 Jan-Mar       Impact factor: 1.383

3.  Structural and functional brain alterations in patients with myasthenia gravis.

Authors:  Benita Klaus; Patrick Müller; Nora van Wickeren; Milos Dordevic; Marlen Schmicker; Yael Zdunczyk; Tanja Brigadski; Volkmar Leßmann; Stefan Vielhaber; Stefanie Schreiber; Notger G Müller
Journal:  Brain Commun       Date:  2022-02-01

4.  Cardiac Autonomic Dysfunction in Myasthenia Gravis and Relapsing-Remitting Multiple Sclerosis-A Pilot Study.

Authors:  Łukasz Rzepiński; Monika Zawadka-Kunikowska; Julia L Newton; Paweł Zalewski
Journal:  J Clin Med       Date:  2021-05-18       Impact factor: 4.241

5.  Cognitive impairment as a central cholinergic deficit in patients with Myasthenia Gravis.

Authors:  Antonia Kaltsatou; Dimitris Fotiou; Dimitris Tsiptsios; Anastasios Orologas
Journal:  BBA Clin       Date:  2015-04-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.